Advertisement
Ear/Nose/Throat
Subscribe to Ear/Nose/Throat
View Sample

FREE Email Newsletter

FDA Grants Full Approval for PROMACTA® (eltrombopag) for Treatment of Rare Blood Disorder

February 25, 2011 10:36 pm | by Bio-Medicine.Org | News | Comments

PHILADELPHIA, Feb. 25, 2011 /- GlaxoSmithKline (NYSE: GSK ) today announced that the United States Food and Drug Administration (FDA) granted full approval for PROMACTA® (eltrombopag), an oral tablet that can raise platelet counts in patients with the rare blood disorder chronic...

Social Networking's Newest Friend: Genomics

February 23, 2011 7:33 pm | by Massachusetts Institute of Technology | News | Comments

The first large-scale study to combine genome sequencing and social-network analysis solves a mysterious TB outbreak.

Using Amphetamines May Increase Risk of Parkinson's Disease

February 22, 2011 7:35 am | by Bio-Medicine.Org | News | Comments

ST. PAUL, Minn., Feb. 22, 2011 /PRNewswire-USNewswire/ -- New research shows people who have used amphetamines such as benzedrine and dexedrine appear to be at an increased risk of developing Parkinson's disease, according to a study released today that will be presented at the American...

Advertisement

ASU, Mayo Clinic enhance collaboration with formal commitment

February 14, 2011 7:34 am | by Arizona State University | News | Comments

ASU and Mayo Clinic have signed an agreement to broaden and deepen their collaboration in health care, medical research and education.read more

OXIS International to Present at the Lippert/Heilshorn Life Sciences and Medtech Virtual Conference on February 17

February 14, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

BEVERLY HILLS, Calif., Feb. 14, 2011 /- OXIS International, Inc., (OTC Bulletin Board: OXIS ;  Paris: OXI) today announced that Anthony Cataldo, Chief Executive Officer, and Bernie Landes, President, will present to investors as part of the Lippert/Heilshorn & Associates Life...

Research Team Honored for Innovative Science to Advance Cancer Research

February 10, 2011 6:33 am | by AACR | News | Comments

ORLANDO, Fla. - The Fifth Annual AACR Team Science Award will be given to a team of internationally renowned molecular biologists, epidemiologists, biostatisticians and clinicians from Fred Hutchinson Cancer Research Center and University of Washington who have worked together on human...

The Villages Charter School Receives Donation From Praxis EMR

February 8, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

THE VILLAGES, Fla., Feb. 8, 2011 /- Today, The Villages Charter School announced receipt of supplies and equipment donated by Praxis: The Template-Free EMR. Praxis made the donation soon after learning of the school's plans to begin using its electronic medical records system as part of...

Missouri Baptist Medical Center - Only Non-Teaching Hospital in Region to Offer Colorectal Cancer Patients Robotic Surgery

February 3, 2011 7:30 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Feb. 3, 2011 /- Missouri Baptist Medical Center now provides patients with a new, minimally invasive surgical treatment option for colorectal cancer – robotic surgery with the da Vinci®-S™ Surgical System.  Eric D. Lederman, MD, a board certified general...

Advertisement

Boston Scientific Announces FDA Approval of Renegade® HI-FLOâ„¢ Fathom® Pre-Loaded System

January 31, 2011 3:31 am | by Boston Scientific | News | Comments

New system integrates market-leading Renegade HI-FLO Microcatheter with high-torque Fathom-16 Steerable Guidewire for peripheral embolization procedures

Not Resting on Its Laurels, Startup Focusing on Sleep Disorders

January 24, 2011 8:32 am | by San Diego Business Journal | News | Comments

With business partners such as Roche and Stanford University already on board to test its wireless brain recording technology, NeuroVigil Inc. is looking to make some other smart moves in 2011.

CVS Caremark Study Evaluates Which Pharmacy Channel Consumers Choose When Given Choice of Mail or Retail Prescriptions

January 19, 2011 8:37 am | by Bio-Medicine.Org | News | Comments

WOONSOCKET, R.I., Jan. 19, 2011 /- When consumers are offered a cost-neutral choice to fill their 90-day prescription medications in a retail store or through a mail-order pharmacy, they split their preferences largely depending on their past experiences, a first-of-its-kind study from...

Nuance Health Introduces Swype, an Innovative New Product Designed to Enhance Defense Against Colds and Flu

January 19, 2011 4:38 am | by Bio-Medicine.Org | News | Comments

PONTE VEDRA BEACH, Fla., Jan. 19, 2011 /- Nuance Health, LLC, a company that develops products designed to help people maintain good health, today introduced Swype, a new product that enhances defense against viruses at the body's most vulnerable spot – the nose.  In...

Spotting Alzheimer's Disease Early

January 18, 2011 7:39 pm | by Massachusetts Institute of Technology | News | Comments

An experimental tracer detects signs of the disorder in living patients.

Advertisement

Pharmacists Offer Recommendations to Guide Public Through Cold and Flu Season

January 18, 2011 10:43 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Jan. 18, 2011 /PRNewswire-USNewswire/ -- The American Pharmacists Association would like to remind the public about the importance of speaking with their pharmacist during cold and flu season. A pharmacist can help patients with such things as getting a flu shot, identifying...

Kinesiology joins College of Nursing & Health Innovation

January 11, 2011 12:34 pm | by Arizona State University | News | Comments

Kinesiology traces its origins to 1896 when the Tempe Normal College added Physical Education to its academic programs.read more

Genetics Squared Changes Name To Everist Genomics

January 10, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

ANN ARBOR, Mich., Jan. 10, 2011 /- Genetics Squared, a prognostics company focused on developing gene-based molecular assays for the prediction of cancer recurrence, today announced that it will change its corporate name to Everist Genomics and has appointed Prasad Sunkara, Ph.D. as its...

IRIDEX to Present at the OneMedForum San Francisco 2011 Conference

January 6, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Jan. 6, 2011 /- IRIDEX Corporation (Nasdaq: IRIX ) today announced that management will present at the OneMedForum San Francisco 2011 Conference at 8:45 a.m. PST on Tuesday, January 11.  The conference will be held on January 11-13 at the Sir Francis Drake...

Centocor Ortho Biotech Inc. Submits Application to FDA Seeking REMICADE® Pediatric Ulcerative Colitis Indication

December 29, 2010 4:36 am | by Bio-Medicine.Org | News | Comments

HORSHAM, Pa., Dec. 29, 2010 /- Centocor Ortho Biotech Inc. announced today that it has filed a supplemental Biologics License Application (sBLA) with the U.S. Food and Drug Administration (FDA) requesting the approval of REMICADE® (infliximab) for the treatment of moderately to...

Accuray Incorporated's CEO to Speak at 29th Annual J.P. Morgan Healthcare Conference

December 28, 2010 8:35 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Dec. 28, 2010 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that its president and chief executive officer, Euan S. Thomson, Ph.D., is scheduled to present at the 29th Annual J.P. Morgan Healthcare Conference in...

On Average, 55 Percent of Surveyed U.S. Asthma Patients Say They Are Likely to Request a Switch to a Drug With Efficacy Comparable to Their Current Medication but Which is Dos...

December 21, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

BURLINGTON, Mass., Dec. 21, 2010 /- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that an average of 55 percent of surveyed asthma patients in the U.S. report that they are likely or very likely to request a...

Critical Care Nurses Do Not Have Access to Tools They Need to Treat Sepsis

December 21, 2010 7:33 am | by Bio-Medicine.Org | News | Comments

DURHAM, N.C., Dec. 21, 2010 /- bioMerieux, a world leader in the field of in vitro diagnostics, announced the results of a survey demonstrating that most critical care nurses are unaware of a simple diagnostic test that may dramatically improve outcomes for sepsis patients. The survey,...

New Software for Improving the Analysis of OCT Images

December 20, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

PINE BROOK, N.J., Dec. 20, 2010 /- Diopsys, Inc. today announced the development of software that uses existing Spectral Domain Optical Coherence Tomography (SD-OCT) images to assist ophthalmologists and optometrists in diagnosing retinal and optic nerve disease such as glaucoma.  ...

Non-Profit Breastcancer.org Shares Concerns with FDA on Avastin Breast Cancer Recommendation

December 16, 2010 8:32 pm | by Bio-Medicine.Org | News | Comments

ARDMORE, Pa., Dec. 16, 2010 /PRNewswire-USNewswire/ -- Dr. Marisa Weiss, president and founder of Breastcancer.org and a breast oncologist in the Philadelphia area submitted a letter to the U.S. Food and Drug Administration prior to the Oncology Drug Advisory Committee (ODAC) meeting to...

Improvements in Recurrence-Free Survival in Early Stages of Colorectal Cancer Will Limit Growth of Drug Treatment Opportunities for Advanced Disease

December 16, 2010 9:35 am | by Bio-Medicine.Org | News | Comments

BURLINGTON, Mass., Dec. 16, 2010 /- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that projected improvements in recurrence-free survival in early stages of colorectal cancer is the most important factor limiting...

Guardian 24/7 Offers Remote High-Touch Health Care via Glowpoint Video Managed Services

December 16, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

HILLSIDE, N.J., Dec. 16, 2010 /- Glowpoint, Inc. (OTC Bulletin Board: GLOW ), a provider of cloud-based managed services for telepresence , video conferencing and collaboration , today announced that Guardian 24/7, a health care provider for high-profile executives, has selected...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading